BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35580545)

  • 1. Generation of a human induced pluripotent stem cell line (JSPHi002-A) from a patient with long-QT syndrome type 1 caused by KCNQ1 c.773A > T mutation.
    Wang Q; Zhang Y; Zhang F; Li Z; Cheng H; Lin Y; Zhu Y; Chen H; Cui C; Chen M
    Stem Cell Res; 2022 Jul; 62():102810. PubMed ID: 35580545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Zhang H; Jahng JWS; Liu Y; Chase AJ; Perez MV; Wu JC
    Stem Cell Res; 2021 Aug; 55():102492. PubMed ID: 34411974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
    Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
    Lee Y; Park H; Kyung Koo S; Kim JH
    Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation.
    Ge N; Liu M; Ding Y; Krawczyk J; McInerney V; Galvin J; Shen S; Prendiville T; O'Brien T
    Stem Cell Res; 2019 Dec; 41():101650. PubMed ID: 31765965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
    Wang H; Guo T; Lan F
    Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
    Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression-Replacement
    Dotzler SM; Kim CSJ; Gendron WAC; Zhou W; Ye D; Bos JM; Tester DJ; Barry MA; Ackerman MJ
    Circulation; 2021 Apr; 143(14):1411-1425. PubMed ID: 33504163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.
    Lavra L; Magi F; Ulivieri A; Morgante A; Paulis M; Sala L; Pedrazzini M; Polisca P; Rocchetti M; Calò L; Sciacchitano S; Salehi LB
    Stem Cell Res; 2021 Jul; 54():102418. PubMed ID: 34130155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
    Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
    Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
    N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101431. PubMed ID: 30974404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
    Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
    [No Abstract]   [Full Text] [Related]  

  • 18. Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benign.
    Clemens DJ; Lentino AR; Kapplinger JD; Ye D; Zhou W; Tester DJ; Ackerman MJ
    Heart Rhythm; 2018 Apr; 15(4):555-561. PubMed ID: 29197658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCNQ1 mutations associated with Jervell and Lange-Nielsen syndrome and autosomal recessive Romano-Ward syndrome in India-expanding the spectrum of long QT syndrome type 1.
    Vyas B; Puri RD; Namboodiri N; Nair M; Sharma D; Movva S; Saxena R; Bohora S; Aggarwal N; Vora A; Kumar J; Singh T; Verma IC
    Am J Med Genet A; 2016 Jun; 170(6):1510-9. PubMed ID: 27041150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.
    Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
    Stem Cell Res; 2019 Apr; 36():101416. PubMed ID: 30878014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.